首页> 美国卫生研究院文献>Journal of Clinical and Diagnostic Research : JCDR >Extramedullary Solitary Plasmacytoma: Demonstrating the Role of 18F-FDG PET Imaging
【2h】

Extramedullary Solitary Plasmacytoma: Demonstrating the Role of 18F-FDG PET Imaging

机译:髓外孤立性浆细胞瘤:证明18F-FDG PET成像的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An Extramedullary Plasmacytoma (EMP) is characterized by a neoplastic proliferation of clonal plasma cells outside the medullary cavity. EMPs are a rare occurrence compared to other malignant plasma cell disorders and account for approximately 3-5% of plasma-cell neoplasms. Although most cases of EMP are not immediately life threatening at diagnosis, EMPs can progress to Multiple Myeloma (MM) and thus, warrant monitoring. Currently, there are no standard guidelines for when and how to monitor patients who are diagnosed with or treated for a solitary plasmacytoma. We present a case of solitary EMP who was treated adequately and definitively but developed a distinct, non-contiguous subsequent solitary EMP and was only discovered due to surveillance 18F-Fludeoxyglucose Positron Emission Tomography (18F-FDG) (PET) scan. Uniform surveillance guidelines should be developed and the potential benefits of PET and other imaging techniques as well as their cost should be considered.
机译:髓外浆细胞瘤(EMP)的特征在于髓腔外克隆浆细胞的肿瘤增生。与其他恶性浆细胞疾病相比,EMP很少发生,约占浆细胞肿瘤的3-5%。尽管大多数EMP病例在诊断时不会立即威胁生命,但EMP可以进展为多发性骨髓瘤(MM),因此需要进行监测。当前,对于何时以及如何监测被诊断或治疗过孤立性浆细胞瘤的患者,尚无标准指南。我们介绍了一个孤立的EMP病例,该病例经过充分和明确的治疗,但出现了明显的,非连续的后续孤立EMP,并且仅由于监视 18 F-氟氧葡萄糖正电子发射断层显像( 18 F-FDG)(PET)扫描。应制定统一的监测指南,并应考虑PET和其他成像技术的潜在利益及其成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号